Insights

Innovative Technology EPIX Therapeutics has developed a highly differentiated catheter ablation system featuring proprietary capabilities such as temperature sensing, low irrigation flow, and high-resolution electrogram attenuation. This unique technological advantage positions the company as a potential leader in advanced AFIB treatment devices, making it attractive for hospitals and clinics seeking cutting-edge solutions.

Regulatory Progress With CE marking for the DiamondTempTM System and ongoing FDA investigational device trials, EPIX is advancing towards broader market access in the US and internationally. These regulatory milestones indicate readiness to scale sales efforts once product approval is achieved, presenting opportunities for early adopters and regional distributors.

Growing Market Potential The global atrial fibrillation treatment market is expanding rapidly, driven by the increasing prevalence of AFIB and the shift towards minimally invasive procedures like catheter ablation. EPIX’s focus on this high-growth market offers significant sales opportunities across healthcare systems looking for innovative and effective interventions.

Strategic Partnerships EPIX’s collaborations and recent funding of $45 million underscore its potential for strategic expansion and development. Engaging with local distributors, medical device network providers, or alignment with large hospital groups could accelerate product adoption and increase revenue streams.

Market Positioning Compared to major industry players with extensive product portfolios, EPIX’s niche focus on AFIB ablation with its proprietary, high-performance system helps target specialized cardiology clinics and electrophysiology labs. This specialized positioning offers the chance to build strong relationships with key opinion leaders and early adopters in electrophysiology.

EPIX Therapeutics, Inc. Tech Stack

EPIX Therapeutics, Inc. uses 7 technology products and services including Microsoft 365, cPanel, RequireJS, and more. Explore EPIX Therapeutics, Inc.'s tech stack below.

  • Microsoft 365
    Email
  • cPanel
    Hosting Panels
  • RequireJS
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Google Analytics
    Web Analytics
  • Apache HTTP Server
    Web Servers
  • Apache
    Web Servers

EPIX Therapeutics, Inc.'s Email Address Formats

EPIX Therapeutics, Inc. uses at least 1 format(s):
EPIX Therapeutics, Inc. Email FormatsExamplePercentage
FLast@actmed.netJDoe@actmed.net
84%
FMiddleLast@actmed.netJMichaelDoe@actmed.net
11%
FirstLast@actmed.netJohnDoe@actmed.net
5%

Frequently Asked Questions

Where is EPIX Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
EPIX Therapeutics, Inc.'s main headquarters is located at 2880 Lakeside Drive Santa Clara, California 95054 United States. The company has employees across 1 continents, including North America.

What is EPIX Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
EPIX Therapeutics, Inc.'s official website is actmed.net and has social profiles on LinkedIn.

What is EPIX Therapeutics, Inc.'s NAICS code?

Minus sign iconPlus sign icon
EPIX Therapeutics, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does EPIX Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of February 2026, EPIX Therapeutics, Inc. has approximately 51 employees across 1 continents, including North America. Key team members include Vice President Research / Development: J. K.Executive Assistant To Chief Executive Officer: M. B.Clinical Affairs Manager: E. L.. Explore EPIX Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does EPIX Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
EPIX Therapeutics, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does EPIX Therapeutics, Inc. use?

Minus sign iconPlus sign icon
EPIX Therapeutics, Inc.'s tech stack includes Microsoft 365cPanelRequireJSjQueryGoogle AnalyticsApache HTTP ServerApache.

What is EPIX Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
EPIX Therapeutics, Inc.'s email format typically follows the pattern of FLast@actmed.net. Find more EPIX Therapeutics, Inc. email formats with LeadIQ.

How much funding has EPIX Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of February 2026, EPIX Therapeutics, Inc. has raised $45M in funding. The last funding round occurred on May 02, 2017 for $45M.

When was EPIX Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
EPIX Therapeutics, Inc. was founded in 2007.

EPIX Therapeutics, Inc.

Medical Equipment ManufacturingCalifornia, United States51-200 Employees

EPIX Therapeutics, Inc. (formerly Advanced Cardiac Therapeutics, Inc.) is a medical device company that designs and manufactures a catheter-based system for the treatment of patients with AFIB.  The Company's mission is to dramatically improve the treatment of AFIB through the introduction of products based on its proprietary catheter and generator system.  EPIX's technology is the only system in the world to leverage three unique capabilities: temperature sensing and feedback, low irrigation flow rates and high resolution electrogram attenuation.  The DiamondTempTM System is limited to investigational use in the United States. 

Founded in 2007, the company has pioneered the development of catheter ablation solutions for the treatment of atrial fibrillation and other arrhythmias.  In 2014, the company brought in industry veteran Duke Rohlen as Chairman and CEO.  Rohlen built a team that developed a novel technology, the DiamondTempTM radiofrequency ablation system, designed to treat patients with AFIB.  In late 2017, the DiamondTempTM system received CE Marking for the device, and FDA approval of an investigational device evaluation application (IDE) to commence a 480-subject, multicenter, global, pivotal trial (Diamond-AF) to treat patients with paroxysmal AFIB.  The company expects to complete the enrollment of this IDE study the end of 2018.

The DiamondTemp™ is a medical device and is subject to applicable country and/or regional regulations.

Atrial fibrillation is a condition in which the heart beats irregularly due to improper electrical impulses and is one of the most prevalent heart diseases globally, currently affecting an estimated six million people in the U.S. alone. The irregular heart beat can lead to increased risk of stroke and significant diminishment of quality of life for affected individuals.  Catheter ablation has been demonstrated to be a safe, effective, and economic treatment for atrial fibrillation.  The catheter ablation market is one of the fastest growing medical device markets today.

Section iconCompany Overview

Headquarters
2880 Lakeside Drive Santa Clara, California 95054 United States
Website
actmed.net
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2007
Employees
51-200

Section iconFunding & Financials

  • $45M

    EPIX Therapeutics, Inc. has raised a total of $45M of funding over 6 rounds. Their latest funding round was raised on May 02, 2017 in the amount of $45M.

  • $1M

    EPIX Therapeutics, Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $45M

    EPIX Therapeutics, Inc. has raised a total of $45M of funding over 6 rounds. Their latest funding round was raised on May 02, 2017 in the amount of $45M.

  • $1M

    EPIX Therapeutics, Inc.'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.